InvestorsHub Logo
Followers 43
Posts 2649
Boards Moderated 0
Alias Born 03/11/2017

Re: poincianamike post# 6787

Thursday, 05/11/2017 6:40:08 AM

Thursday, May 11, 2017 6:40:08 AM

Post# of 50157
Oh pleeeeease. Such a ridiculous statement.

The percentage of companies that are capable of doubling overall survival rate is minuscule.

The need for Isolated delivery of cancer drugs to an organ is surely in demand. Very often, the drugs are too strong and they essentially poison people to death. Patients diagnosed with metastatic ocular melanoma to the liver have an average of 6-8 months to live. Delcath extends that by YEARS

Hence, The Delcath Method will be instrumental in the future medicine.

And for those reasons, I'm not even going to entertain your comment. It's LAUGHABLE
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DCTH News